Adaptimmune Therapeutics plc, a clinical-stage biopharmaceutical company, provides novel cell therapies primarily to cancer patients in the United States ... Community · Statistics · Historical Data · Profile

Find the latest Adaptimmune Therapeutics plc (ADAP) stock quote, history, news and other vital information to help you with your stock trading and ...

Adaptimmune Therapeutics plc (NASDAQ:ADAP), a company working to redefine the treatment of solid tumor cancers with cell therapy.

At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio ... ADAP 0.6616. Tip: Try a valid symbol or a specific company name for relevant ...

See Adaptimmune Therapeutics plc (ADAP) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades.

Find the latest Adaptimmune Therapeutics plc (ADAP) stock discussion in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders ...

Discover historical prices for ADAP stock on Yahoo Finance. View daily, weekly or monthly format back to when Adaptimmune Therapeutics plc stock was issued.

Interactive Chart for Adaptimmune Therapeutics plc (ADAP), analyze all the data with a huge range of indicators.

See Adaptimmune Therapeutics plc (ADAP) Environment, Social and Governance Ratings to help you in your stock buying decisions.

See the company profile for Adaptimmune Therapeutics plc (ADAP) including business summary, industry/sector information, number of employees, ...